Skip to main content
SpringerLink
Log in

Improve treatment of multiple sclerosis by defining specific pain syndromes and analysing their relationship to the disease

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I

References

  1. Pöllmann W, Feneberg W, Erasmus L-P. Pain in multiple sclerosis: a still underestimated problem. The 1-year prevalence of pain syndromes, significance and quality of care of multiple sclerosis inpatients [in German]. Nervenarzt 2004; 75(2): 135–40

    Article  PubMed  Google Scholar 

  2. Pöllmann W, Feneberg W. Current management of pain associated with multiple sclerosis. CNS Drugs 2008; 22(4): 291–324

    Article  PubMed  Google Scholar 

  3. Pöllmann W, Feneberg W, Steinbrecher A, et al. Therapy of pain syndromes in multiple sclerosis: an overview with evidence-based recommendations [in German]. Fortschr Neurol Psychiatr 2005; 73(5): 268–85

    Article  PubMed  Google Scholar 

  4. Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. EFNS Task Force. Eur J Neurol 2006; 13(11): 1153–69

    Article  PubMed  CAS  Google Scholar 

  5. Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology 1995; 45(7): 1294–6

    Article  PubMed  CAS  Google Scholar 

  6. Obermann M, Yoon MS, Sensen K, et al. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 2008; 28(2): 174–81

    PubMed  CAS  Google Scholar 

  7. Minagar A, Sheremata WA. Glossopharyngeal neuralgia and MS. Neurology 2000; 54(6): 1368–70

    Article  PubMed  CAS  Google Scholar 

  8. Klewer J, Pöhlau D, Nippert I, et al. Problems reported by elderly patients with multiple sclerosis. J Neurosci Nurs 2001; 33(3): 167–71

    Article  PubMed  CAS  Google Scholar 

  9. Henze T, Rieckmann P, Toyka KV. Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society. Eur Neurol 2006; 56(2): 78–105

    Article  PubMed  CAS  Google Scholar 

  10. Kidd BL, Langford RM, Wodehouse T. Arthritis and pain: current approaches in the treatment of arthritic pain. Arthritis Res Ther 2007; 9(3): 214

    Article  PubMed  Google Scholar 

  11. Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol 2006; 25Suppl. 1: 22–9

    Article  Google Scholar 

  12. Pöllmann W, Erasmus L-P, Feneberg W, et al. Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 2002; 59(4): 636–9

    Article  PubMed  Google Scholar 

  13. Katz U, Kishner I, Magalashvili D, et al. Long-term safety of IVIg therapy in multiple sclerosis: 10 years experience. Autoimmunity 2006 Sep; 39(6): 513–7

    Article  PubMed  Google Scholar 

  14. Evers S, Afra J, Frese A, et al. EFNS guidelines on the drug treatment of migraine: report of an EFNS task force. Eur J Neurol 2006; 13(6): 560–72

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Improve treatment of multiple sclerosis by defining specific pain syndromes and analysing their relationship to the disease. Drugs Ther. Perspect 25, 14–17 (2009). https://doi.org/10.2165/0042310-200925010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/0042310-200925010-00004

Search

Navigation